Makes xylazine a Schedule III controlled substance

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

7309S.01I - Introduced — · 7.5K words Open full page ↗

SECOND REGULAR SESSION

SENATE BILL NO. 1724

103RD GENERAL ASSEMBLY

INTRODUCED BY SENATOR BROWN (16).

7309S.01I KRISTINA MARTIN, Secretary

AN ACT

To repeal section 195.017, RSMo, and to enact in lieu thereof one new section relating to xylazine.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Floor Consideration — base rate 2%, measured from MO's completed sessions
Momentum -2 39/100 from the pace of recorded action
Time since last action -22 229 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.